Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I hope you right, but I see more pain ahead. all points
Market collapsing. Gold is Probably only Safe Asset left.
let's face it, Trump is the main reason, economy still strong. link back
Northland analyst Carl Byrne initiated Aytu BioScience with an Outperform and $10 price target.
Read more at:
https://thefly.com/landingPageNews.php?id=2808018ttps://thefly.com/landingPageNews.php?id=2808018&headline=AYTU-Aytu-BioScience-initiated-with-an-Outperform-at-Northland
Great device, these internet. Never forgets. https://t.co/PHIJI4s69t
Northland Capital Markets Starts Aytu Biosciences (AYTU) at Outperform PT $10 Northland Capital focuses on growth companies and institutional investors. Northland Capital serves customers throughout the United States.
Buying DTEA $2.5, trading 40% below Net Assets. Super gift
From Q2 Transcript :
"I am confident that our shareholders will see improved results within the next nine months
Last month, we launched an excellent program with Loblaw Companies and are now in 450 stores across Canada"
"We are building a strong team and we have put more senior leaders in buying, marketing and product development... As well, we are ready to find a CEO who will enthusiastically adapt to the DAVIDsTEA environment...We have now entered a new era at DAVIDsTEA"
$90m Net Assets vs $60m MC
One of most important chart I have seen:
https://www.topdowncharts.com/single-post/2018/08/18/Chart-SP500-Long-Term-Earnings-Growth-Outlook
It seems, going to smack Y2K Earnings Growth.
Also New CEO soon. This will fly. Herschel Segal: "we have made adjustments at head office to change our operations and our culture. We are building a strong team and we have put more senior leaders in buying, marketing and product development. We are also paying more attention to our costs. As well, we are ready to find a CEO who will enthusiastically adapt to the DAVIDsTEA environment, lead with a realistic optimism and bring vision that will be refined and further developed with the senior executive team and the company's board".
I do see a little optimism .economy is still strong. American Express, PayPal and Skechers all posted on Thursday earnings that topped analyst expectations.
I tried to explain it several times.not surprised to see the stock market collapsing
Thank you. Even without CBD, stock is trading about 30% below Net Assets. Ownership is one of highest the Sector. Did you know that most Pot Stocks trading 10 to 200 even more their Net Assets ( Equity) , many have a negative Equity. So imagine the upside potential on $90M Net Assets. W/CBD in ( no competition in Canada) , this is a Billion Dollar Company a few months later if you ask me.
most my comments been reporting later https://www.cnbc.com/2018/10/18/us-stocks-are-vulnerable-when-china-stocks-fall-hard.html
CIIX thank you MazelTov.
Agree. total Equity(Net Assets) $90m, Or $3.5/sh (Cash on hand $39m), vs $65m Market cap. its not even started with CBD drink but potential is very high for both (CBD, buy-out) many are knocking Company's Door.. only upside from this low MC. 86% ownership, they will never sell below Net assets/Equity. no competition in Canada. Put CBD In their Tea and you have first product in trillions dollar market.
LONG.
Maybe next PTI (370%)? PTIE Waking: a solution possibility for Alzheimer. other reasons: insiders buys, Solid Balance sheet, low MC, and 2 weeks ago: $3.5 million research grant from the National Institutes of Health (NIH).
Waking. Probably due to a solution possibility for Alzheimer. other reasons: insiders buys, Solid Balance sheet, low MC, and 2 weeks ago: $3.5 million research grant from the National Institutes of Health (NIH).
ORPN my lotto hit $2.3 today. $1.9 +44%. sold most kept a few.
that's not what I said. my point is- a lose lose situation for both
I have mentioned a Boomerang Effect. If Chinese becomes poorer, can they afford iPhones, iPads, etc? Trump is shooting himself in the foot with Tariffs
United States 10-Year Bond Yield
3.213 +0.034 +1.06%
United States 30-Year Bond Yield
3.382 +0.036 +1.07%
the FED was right yesterday while hinted about more rate hikes.
AYTU Great interview/updates..
Dr. Ranjith Ramasamy, is the study’s principal investigator, AYTU's study which being conducted at the University of Miami’s Department of Urology these days.
https://www.winway.me/health-remedies/new-testosterone-nasal-gel-natesto-data-interview-with-dr-ramasamy/
Nice catch.
INSY looking good. $10 break ?
Yes indeed
CBD stocks on fire.
ZYNE $7.16 At least 2 Catalysts H2 2018+NDA ( could be any time) + One of the many drugs in its pipeline is ZYN002, the only cannabidiol gel currently undergoing FDA trials+ it has three Phase II studies underway. Fully Funded Into H1 2020 ( see pic) https://twitter.com/ash_trader/status/1050814290842796032
Hi, MTH4, MICT Revenue increased by 25% and 65% to $4.7 million and $10.7 million for the three and six months ended June 30, 2018, respectively. Profit Margin expected to Increase no matter BNN deal. Its a complex merger, If i got it right:
BNN Technology acquired a 14.89% stake in the company at $1.65/sh
BNN + another co. will buy an additional 35% stake of at least $1.65/share ( to 50.1% Ownership) and will be trading at $160m.
MICT to raise $26-$36m and will acquire BNN.
Btw, i think you are holding potential pot stocks. I also own a few you have mentioned
$ZYNE
Major Catalysts ahead ( Q4). new Presentation on Board. Consensus P.T By 5 Analysts is around $21
One of the many drugs in its pipeline is ZYN002, the only cannabidiol gel currently undergoing FDA trials — it has three Phase II studies underway.fully Funded.
Arlinda Lee,PhD
Success Rate on Stock 50%
https://t.co/9M96hzxwPX
"ZYN002 could provide the basis for regulatory approval"..
Gets Buy Rating, $25.50 Target Price From Ladenburg Thalman
Higgins also thinks that Zynerba has an advantage over GW Pharmaceuticals’ Epidiolex drug.
https://www.greenmarketreport.com/zynerba-gets-buy-rating-25-50-target-price-ladenburg-thalman/
$ZYNE analyst number 3.
CANTOR FITZGERALD
We rate 12-month PT of $20/share. Zynerba is developing ZYN002, a synthetic CBD gel to treat neurological conditions.
https://t.co/Tv0javh00T https://t.co/EHAqaPzXIl
Form SC 13G AYTU BIOSCIENCE, INC Filed by: CVI Investments, Inc.
Reported 9.9% Stake in $AYTU
https://t.co/T1ULx97oij
Cash/sh close to $2, fully funded now financing just completed.
$ZYNE Gets Buy Rating, $25.50 Target Price From Ladenburg Thalman
Higgins also thinks that Zynerba has an advantage over GW Pharmaceuticals’ Epidiolex drug.
$GWPH
https://www.greenmarketreport.com/zynerba-gets-buy-rating-25-50-target-price-ladenburg-thalman/
ZYNE
Arlinda Lee,PhD
Success Rate on Stock 50%
https://t.co/9M96hzxwPX
"ZYN002 could provide the basis for regulatory approval"..
ZYNE When funds will start loading it will be too late and share price will skyrocket. Ownership is high and not many tradable share out there.
Major Catalysts ahead ( Q4). new Presentation on Board. Consensus P.T By 5 Analysts is around $21
One of the many drugs in its pipeline is ZYN002, the only cannabidiol gel currently undergoing FDA trials — it has three Phase II studies underway. fully Funded. A very solid Balance sheet and Insiders are Buying Crazy here
Treasuries: Yield back down sharply after more than a week of fast Climbing.
United States 30-Year Bond Yield is down almost 2%. Good news.
Bond Market points of a Green Day ahead
Pay Special attention to After hours movers today on one of the worst day in Wall-Street. These should be on RADAR.
After hours movers:
$DIS $TEVA $ZYNE $AMRN $TLRY $DRYS $RIOT $AYTU $DTEA